SHANK3 goes by various names, such as SH3 and proline-rich synapse-associated protein 2 or ProSAP2. It’s a protein in humans encoded by...

SHANK3 is the most prominent gene in autism patients. It has mutations that range from 1 to 2% among people who have autism spectrum...

We are excited to share the announcement of our first gene-based therapeutic program for Phelan-McDermid syndrome! CureSHANK is proud to...

CureSHANK is a proud member of COMBINEDbrain a non-profit consortium of 25 patient-advocacy groups, each representing a different rare...

What do the SHANK3 gene and Phelan-McDermid Syndrome have to do with autism? Based on the existing research that’s been done, they have a...

Individuals who have Phelan-McDermid Syndrome are one in 15,000! While rare diseases may impact fewer people than widespread illnesses,...

Daria - the daughter of CureSHANK’s co-founder Paulina Rychenkova, - is officially a teenager today! This beautiful young women has...

Did you know - only 30% of adults have a seizure emergency action plan, yet 3.5 million Americans have epilepsy? All people living with...

Mice play an important role in the development of therapies for rare diseases like Phelan-McDermid Syndrome. These little guys make a big...

What is Phelan-McDermid Syndrome? What are its symptoms? How many people are affected? These are questions that caregivers of individuals...

What an onerous year it has been for so many of us, especially for families who have children with neurodevelopmental disabilities. The...

We are proud to be participating in Healx's webinar on the development of in vitro models for rare disease research on August 13....